Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Nanoparticles for cancer therapy, imaging and drug delivery.

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.

AnDy marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Domain-centric intelligent automated data extraction methodology.

Oxbotica. Robotics, autonomous systems, driverless pods.

At OxSyBio, we are developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Our vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.

Professor Bayley’s group have previously demonstrated the ability to print three-dimensional networks comprising tens of thousands of picoliter aqueous droplets forming a cohesive material. These networks can be built in software-controlled geometries using a number of different droplet types, thus enabling them to perform simple cell-like functions and act as ‘tissue-like’ materials. Initial work showed that printed networks were capable of conducting electrical signals along neuron-like pathways by the selective incorporation of membrane proteins, or to fold in a pre-defined manner to assume altered shapes after printing.

OxSyBio is refining and advancing this technology to print more complex networks more rapidly and at a higher resolution. We are also adapting the approach to print living cells inside droplets, which will enable the direct printing of 3D cell networks with many of the characteristics of living tissues.

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.

A private biopharmaceutical company focused on the development of therapies for retinal dystrophies.

A rapidly grown, energetic company specializing in translational and regenerative medicine.

Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.

Developing solutions for major unmet needs in diagnostic medicine in multiple internal organs. In the first instance the focus will be on, the detection and the accurate, quantitative measurement of liver, gallbladder and pancreatic disease, including precancerous and cancerous states in these organs.

Offering the most accurate assessment of running biomechanics that modern science is able to provide.

Cellular immunity vaccines.

Revolutionary healthcare technology that measures medical vital signs without physical contact.